drug discovery
30 articles about drug discovery in AI news
DrugPlayGround Benchmark Tests LLMs on Drug Discovery Tasks
A new framework called DrugPlayGround provides the first standardized benchmark for evaluating large language models on key drug discovery tasks, including predicting drug-protein interactions and chemical properties. This addresses a critical gap in objectively assessing LLMs' potential to accelerate pharmaceutical research.
Beyond General AI: How Liquid Foundation Models Are Revolutionizing Drug Discovery
Researchers have developed MMAI Gym, a specialized training platform that teaches AI the 'language of molecules' to create more efficient drug discovery models. The resulting Liquid Foundation Models outperform larger general-purpose AI while requiring fewer computational resources.
Eli Lilly Signs $2.75B AI Drug Discovery Deal with Insilico Medicine
Eli Lilly has entered a $2.75 billion licensing pact with Insilico Medicine for multiple AI-discovered drug programs. The deal includes an upfront payment, milestones, and royalties, marking a major validation for AI-driven pharmaceutical R&D.
RxnNano: How a Tiny AI Model Outperforms Giants in Chemical Discovery
Researchers have developed RxnNano, a compact 0.5B-parameter AI model that outperforms models ten times larger in predicting chemical reactions. Using innovative training techniques that prioritize chemical understanding over brute-force scaling, it achieves 23.5% better accuracy on key benchmarks for drug discovery applications.
XtalPi's Profit Milestone Signals AI's Transformative Impact on Pharmaceutical Discovery
Chinese AI drug discovery firm XtalPi projects its first annual profit in 2025 following a 193% revenue surge, marking a pivotal moment for AI-driven pharmaceutical research. The company's turnaround demonstrates the commercial viability of AI in accelerating drug development pipelines.
Lilly's AI Factory: How a 9,000+ GPU SuperPOD is Rewriting Pharmaceutical Discovery
Eli Lilly has launched 'LillyPod,' the world's most powerful privately-owned AI factory for drug discovery. Powered by NVIDIA's new DGX B300 systems with over 1,000 Blackwell Ultra GPUs, it promises to accelerate medical breakthroughs at unprecedented scale.
OpenAI's 'Autonomous AI Researchers' Vision Sparks Debate on Biology's 'ChatGPT Moment'
A tweet highlights OpenAI's repeated references to 'autonomous AI researchers' as signaling a 'ChatGPT moment for biology,' suggesting AI could accelerate drug discovery by orders of magnitude. The claim draws a direct analogy to AlphaFold's impact on structural biology.
The AI-Powered 'Cocktail': How One Injection Could Revolutionize Healthcare by 2029
A leading AI researcher predicts that within five years, personalized medical treatments delivered via single injections or pills will become reality. This breakthrough promises to democratize access to advanced healthcare through AI-driven drug discovery and delivery systems.
From Code to Discovery: The Next Frontier of AI Agents in Research
AI researcher Omar Saray predicts a shift from 'agentic coding' to 'agentic research'—where AI systems will autonomously conduct scientific discovery. This evolution promises to accelerate innovation across disciplines.
Anthropic Acquires AI Biotech Coefficient Bio for ~$400M to Build 'Virtual Biologist'
Anthropic acquired AI biotech startup Coefficient Bio for approximately $400M. The small team was building AI to plan drug R&D, manage clinical strategy, and identify new drug opportunities, aligning with CEO Dario Amodei's vision of AI as a 'virtual biologist.'
BloClaw: New AI4S 'Operating System' Cuts Agent Tool-Calling Errors to 0.2% with XML-Regex Protocol
Researchers introduced BloClaw, a unified operating system for AI-driven scientific discovery that replaces fragile JSON tool-calling with a dual-track XML-Regex protocol, cutting error rates from 17.6% to 0.2%. The system autonomously captures dynamic visualizations and provides a morphing UI, benchmarked across cheminformatics, protein folding, and molecular docking.
ASI-Evolve: This AI Designs Better AI Than Humans Can — 105 New Architectures, Zero Human Guidance
Researchers built an AI that runs the entire research cycle on its own — reading papers, designing experiments, running them, and learning from results. It discovered 105 architectures that beat human-designed models, and invented new learning algorithms. Open-sourced.
Citadel CEO Ken Griffin Calls AI 'Only Hype' Amid Industry Spend
Citadel CEO Ken Griffin stated AI is 'only hype' and questioned the ROI of massive spending, despite AI's growing integration across industries. This highlights a divide between financial skepticism and technological adoption.
Sam Altman Outlines 3 AI Futures: Research, Operations, Personal Agents
OpenAI CEO Sam Altman outlined three potential outcomes for AI development: systems that conduct scientific research, accelerate company operations, and serve as trusted personal agents. This vision frames the strategic direction for OpenAI and the broader industry.
Inner Ear Gene Therapy Injection Reverses Deafness in All 10 Patients in Clinical Trial
A clinical trial has reported that a single injection of gene therapy into the inner ear successfully reversed deafness in all ten participating patients. This marks a significant threshold in treating genetic hearing loss, with some patients regaining hearing within weeks.
ASI-Evolve Automates AI Research Loop, Discovers 105 Better Linear Attention Designs and Boosts AMC32 Scores by 12.5 Points
Researchers developed ASI-Evolve, an AI system that automates experimental loops in AI research. It discovered 105 improved linear attention variants and boosted AMC32 scores by 12.5 points, demonstrating automated research acceleration.
AI Model Analyzes Blood Proteins to Diagnose Alzheimer's, Parkinson's, ALS, and Stroke with 17,187-Patient Study
An AI model can diagnose Alzheimer's, Parkinson's, ALS, frontotemporal dementia, and stroke from a single blood sample by analyzing protein profiles. It outperformed symptom-based diagnosis at predicting future cognitive decline in a Nature-published study of 17,187 people.
Elon Musk Claims Tesla Optimus Will Surpass Human Surgeons by 2029, Advises Against Medical School
Elon Musk stated Tesla's Optimus humanoid robot will outperform any human surgeon at scale within three years, calling medical school 'pointless.' He predicts universal access to superior medical care within five years.
Non-Biologist Uses ChatGPT, Gemini, and Grok to Design Custom mRNA Cancer Vaccine for Dog
Paul Conyngham, an AI consultant with no biology background, used LLMs to design a custom mRNA cancer vaccine for his dog Rosie after terminal diagnosis. The DIY treatment protocol shows tumor regression in six weeks.
ML Researcher Uses AlphaFold to Design Treatment for Dog's Cancer in Viral Story
A machine learning researcher reportedly used AlphaFold, DeepMind's protein structure prediction AI, to design a potential treatment for his dog's cancer. The story has gained widespread attention online, highlighting real-world applications of AI in biology.
Walmart's Sparky Chatbot Replaces OpenAI's Instant Checkout After 3x Lower Conversion Rates
Walmart is embedding its own Sparky chatbot into ChatGPT and Google Gemini after OpenAI's Instant Checkout feature saw conversion rates three times lower than traditional web purchases. The pivot highlights the challenges of 'agentic commerce' where AI agents complete purchases autonomously.
EMBRAG Framework Achieves SOTA on KGQA Benchmarks via Embedding-Space Rule Generation
Researchers propose EMBRAG, a framework that uses LLMs to generate logical rules from a query, then performs multi-hop reasoning in knowledge graph embedding space. It sets new state-of-the-art on two KGQA benchmarks.
Mirendil: Ex-Anthropic Scientists Launch $1B Venture to Build AI That Thinks Like a Scientist
Former Anthropic researchers are raising $175M at a $1B valuation for Mirendil, a startup aiming to build AI systems for long-term scientific reasoning. The goal is to accelerate breakthroughs in biology and materials science, aligning with a broader industry push toward autonomous AI researchers.
The Coming Compute Surge: How U.S. Labs Are Fueling the Next AI Revolution
Morgan Stanley predicts a major AI breakthrough driven by unprecedented computing power increases at U.S. national laboratories. This infrastructure expansion could accelerate AI capabilities beyond current limitations.
Palantir and NVIDIA Forge Strategic Alliance to Power Next-Generation AI Platforms
Palantir Technologies and NVIDIA have announced a major collaboration to develop enterprise AI platforms. The partnership aims to integrate Palantir's data analytics with NVIDIA's accelerated computing to deliver powerful AI solutions for government and commercial sectors.
AI Research Accelerator: Autonomous System Completes 700 Experiments in 48 Hours, Optimizing Model Training
An AI system autonomously conducted 700 experiments over two days, reducing GPT-2 training time by 11%. This breakthrough demonstrates AI's growing capability to accelerate scientific research and optimize complex processes without human intervention.
ABB and NVIDIA Forge Industrial AI Alliance, Promising 40% Cost Reduction in Robotic Deployment
ABB Robotics and NVIDIA have announced a landmark partnership integrating NVIDIA Omniverse libraries into ABB's RobotStudio platform. The collaboration aims to bridge the sim-to-real gap in industrial robotics, promising deployment cost reductions of up to 40% and 50% faster time-to-market through physically accurate AI simulation.
The Great GPU Scramble: How Hardware Shortages Are Defining the AI Arms Race
Oracle founder Larry Ellison identifies GPU acquisition as the primary bottleneck in AI development, with companies racing to secure limited hardware for breakthroughs in medicine, video generation, and autonomous systems.
LeCun's Radical Vision: Why Superhuman Specialists, Not General AI, Are the Future
Yann LeCun and colleagues propose shifting AI focus from human-like general intelligence to building superhuman adaptable specialists. They argue human intelligence is evolutionarily specialized for survival, not generality, making AGI a flawed goal. The paper introduces Superhuman Adaptable Intelligence as a more practical framework.
OrbEvo: How AI is Revolutionizing Quantum Chemistry Simulations
Researchers have developed OrbEvo, an equivariant graph transformer that predicts quantum wavefunction evolution in molecules, potentially accelerating time-dependent density functional theory simulations by orders of magnitude. The system accurately captures excited state dynamics and optical properties while maintaining physical symmetries.